• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用抗CD3和抗CD28单克隆抗体来克隆和扩增人抗原特异性T细胞。

The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.

作者信息

Riddell S R, Greenberg P D

机构信息

Fred Hutchinson Cancer Research Center, Seattle, WA 98104.

出版信息

J Immunol Methods. 1990 Apr 17;128(2):189-201. doi: 10.1016/0022-1759(90)90210-m.

DOI:10.1016/0022-1759(90)90210-m
PMID:1691237
Abstract

Antigen-specific T cell clones are useful reagents for studies of the fine specificity of antigen recognition and of potential therapeutic use in adoptive immunotherapy for human viral and malignant diseases. Culture methods which require antigen and APC for stimulation can be problematic for the generation and long-term growth of human virus and tumor-specific T cells. We have developed an alternative culture method using monoclonal antibodies to T cell activation molecules, CD3 and CD28, as stimulation to efficiently grow CD4+ and CD8+ antigen-specific T cells from single progenitors and expand T cell clones in long-term culture. This method alleviates the requirement for large amounts of viral or tumor antigens and MHC compatible APC to sustain the growth of virus and tumor-specific T cell clones, and, as demonstrated for CD8+ CMV-specific cytotoxic T cells, overcomes the difficulties cloning CD8+ T cells using virally infected cells as antigen-presenting cells. T cell clones generated and maintained with monoclonal antibody stimulation are rapidly expanded and retain antigen-specific responses after 3 months in culture, suggesting this approach may prove useful for growing large numbers of antigen-specific T cell clones for cellular immunotherapy.

摘要

抗原特异性T细胞克隆是研究抗原识别精细特异性以及用于人类病毒和恶性疾病过继免疫治疗潜在治疗用途的有用试剂。需要抗原和抗原呈递细胞(APC)进行刺激的培养方法对于人类病毒和肿瘤特异性T细胞的产生和长期生长可能存在问题。我们开发了一种替代培养方法,使用针对T细胞活化分子CD3和CD28的单克隆抗体作为刺激,以有效地从单个祖细胞中培养CD4+和CD8+抗原特异性T细胞,并在长期培养中扩增T细胞克隆。该方法减轻了维持病毒和肿瘤特异性T细胞克隆生长对大量病毒或肿瘤抗原以及MHC相容的APC的需求,并且如针对CD8+巨细胞病毒特异性细胞毒性T细胞所证明的,克服了使用病毒感染细胞作为抗原呈递细胞克隆CD8+ T细胞的困难。通过单克隆抗体刺激产生和维持的T细胞克隆迅速扩增,并在培养3个月后保留抗原特异性反应,表明这种方法可能被证明对为细胞免疫治疗培养大量抗原特异性T细胞克隆有用。

相似文献

1
The use of anti-CD3 and anti-CD28 monoclonal antibodies to clone and expand human antigen-specific T cells.使用抗CD3和抗CD28单克隆抗体来克隆和扩增人抗原特异性T细胞。
J Immunol Methods. 1990 Apr 17;128(2):189-201. doi: 10.1016/0022-1759(90)90210-m.
2
CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.CD28 与 B7 的相互作用共刺激由小型静止 T 淋巴细胞介导的原发性同种异体增殖反应和细胞毒性。
J Exp Med. 1992 Feb 1;175(2):353-60. doi: 10.1084/jem.175.2.353.
3
CD30-antigen-specific targeting and activation of T cells via murine bispecific monoclonal antibodies against CD3 and CD28: potential use for the treatment of Hodgkin's lymphoma.通过抗CD3和CD28的鼠双特异性单克隆抗体实现CD30抗原特异性靶向和T细胞激活:在霍奇金淋巴瘤治疗中的潜在应用。
Int J Cancer. 1993 Jul 9;54(5):820-7. doi: 10.1002/ijc.2910540517.
4
Discrete association of CD3 and CD4 molecules in T-cell stimulation acting through the autologous mixed lymphocyte reaction and the CD3/T-cell receptor complex in human autoreactive T-cell clones.通过自身混合淋巴细胞反应和人自身反应性T细胞克隆中的CD3/T细胞受体复合物起作用的T细胞刺激中CD3和CD4分子的离散关联。
Scand J Immunol. 1991 Feb;33(2):141-9. doi: 10.1111/j.1365-3083.1991.tb03744.x.
5
Patterns of costimulation of T cell clones by cross-linking CD3, CD4/CD8, and class I MHC molecules.通过交联CD3、CD4/CD8和I类MHC分子对T细胞克隆进行共刺激的模式。
J Immunol. 1989 Jun 15;142(12):4201-12.
6
Regulatory role of the CD8 antigen in both CD3 and CD2 monoclonal antibody-induced nonspecific cytotoxicity of class I- and class II-allospecific cytotoxic T cell clones.CD8抗原在CD3和CD2单克隆抗体诱导的I类和II类同种异体特异性细胞毒性T细胞克隆的非特异性细胞毒性中的调节作用。
Eur J Immunol. 1988 Dec;18(12):1973-8. doi: 10.1002/eji.1830181216.
7
Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones.麻疹病毒特异性人类T细胞克隆。CD4+辅助/细胞毒性和CD8+细胞毒性T细胞克隆的特异性及功能特征
J Immunol. 1989 Apr 15;142(8):2847-54.
8
4-1BB is superior to CD28 costimulation for generating CD8+ cytotoxic lymphocytes for adoptive immunotherapy.在为过继性免疫治疗产生CD8 + 细胞毒性淋巴细胞方面,4-1BB优于CD28共刺激。
J Immunol. 2007 Oct 1;179(7):4910-8. doi: 10.4049/jimmunol.179.7.4910.
9
Activation and expansion of tumour-infiltrating lymphocytes by anti-CD3 and anti-CD28 monoclonal antibodies.抗CD3和抗CD28单克隆抗体对肿瘤浸润淋巴细胞的激活与扩增
Cancer Immunol Immunother. 1990;32(4):245-50. doi: 10.1007/BF01741708.
10
Induction of specific nonresponsiveness in unprimed human T cells by anti-CD3 antibody and alloantigen.抗CD3抗体和同种异体抗原诱导未致敏人T细胞产生特异性无反应性
J Exp Med. 1990 Dec 1;172(6):1691-700. doi: 10.1084/jem.172.6.1691.

引用本文的文献

1
Direct visualization of chimeric antigen receptors on primary human T cells using STORM super-resolution microscopy.使用STORM超分辨率显微镜对原代人T细胞上的嵌合抗原受体进行直接可视化。
Front Immunol. 2025 Aug 1;16:1632823. doi: 10.3389/fimmu.2025.1632823. eCollection 2025.
2
miRNA-Mediated Regulation of Gene Expression During Early Activation in Jurkat Cells.Jurkat细胞早期激活过程中miRNA介导的基因表达调控
bioRxiv. 2025 Jun 17:2025.06.15.659805. doi: 10.1101/2025.06.15.659805.
3
Using Seahorse Technology as an Efficient Way of Verifying T Cell Stimulation.
使用海马技术作为验证T细胞刺激的有效方法。
Methods Mol Biol. 2025;2904:219-242. doi: 10.1007/978-1-0716-4414-0_16.
4
Dynamic functional assessment of T cells reveals an early suppression correlating with adverse outcome in polytraumatized patients.T细胞的动态功能评估揭示了多创伤患者中与不良预后相关的早期抑制现象。
Front Immunol. 2025 Mar 24;16:1538516. doi: 10.3389/fimmu.2025.1538516. eCollection 2025.
5
Optimizing TIL therapy for uveal melanoma: lessons learned and unlearned from cutaneous melanoma.优化葡萄膜黑色素瘤的肿瘤浸润淋巴细胞疗法:从皮肤黑色素瘤中吸取与未吸取的教训
Immunotherapy. 2025 Mar;17(4):283-291. doi: 10.1080/1750743X.2025.2478808. Epub 2025 Mar 18.
6
Efficient multiplex non-viral engineering and expansion of polyclonal γδ CAR-T cells for immunotherapy.用于免疫治疗的多克隆γδ嵌合抗原受体T细胞的高效多重非病毒工程改造与扩增
bioRxiv. 2024 Oct 15:2024.09.03.611042. doi: 10.1101/2024.09.03.611042.
7
Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn's disease.白细胞功能障碍和 CTLA-4 表达降低与肛周克罗恩病有关。
Clin Exp Immunol. 2024 Jun 20;217(1):78-88. doi: 10.1093/cei/uxae027.
8
Immune evasion of dormant disseminated tumor cells is due to their scarcity and can be overcome by T cell immunotherapies.休眠播散肿瘤细胞的免疫逃逸是由于其数量稀少,而T细胞免疫疗法可以克服这一问题。
Cancer Cell. 2024 Jan 8;42(1):119-134.e12. doi: 10.1016/j.ccell.2023.12.011.
9
Discovery of U2AF1 neoantigens in myeloid neoplasms.髓系肿瘤中 U2AF1 新抗原的发现。
J Immunother Cancer. 2023 Dec 12;11(12):e007490. doi: 10.1136/jitc-2023-007490.
10
Virus-Specific T-Cell Therapy for Viral Infections of the Central Nervous System: A Review.病毒特异性 T 细胞疗法治疗中枢神经系统病毒感染:综述。
Viruses. 2023 Jul 6;15(7):1510. doi: 10.3390/v15071510.